Impact of novel screening technologies on ion channel drug discovery

被引:18
作者
Lue, Qiang [1 ]
An, W. Frank [2 ,3 ]
机构
[1] Novartis Inst BioMed Res, Lead Finding Platform, Cambridge, MA 02139 USA
[2] Broad Inst Harvard, Cambridge, MA 02142 USA
[3] MIT, Cambridge, MA 02142 USA
关键词
ion channel; automated patch clamp; high throughput screening; electrophysiology; drug discovery;
D O I
10.2174/138620708783877735
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Ion channels are a large superfamily of membrane proteins that pass ions across membranes. They are critical to diverse physiological functions in both excitable and nonexcitable cells and underlie many diseases. As a result, they are an important target class which is proven to be highly "druggable". However, for high throughput screening (HTS), ion channels are historically difficult as a target class due to their unique molecular properties and the limitations of assay technologies that are HTS-amendable. In this article, we describe the background of ion channels and current status and challenges for ion channel drug discovery, followed by an overview of both conventional and newly emerged ion channel screening technologies. The critical impact of such new technologies on current and future ion channel drug discovery is also discussed.
引用
收藏
页码:185 / 194
页数:10
相关论文
共 66 条
[1]   Sotalol: An important new antiarrhythmic [J].
Anderson, JL ;
Prystowsky, EN .
AMERICAN HEART JOURNAL, 1999, 137 (03) :388-409
[2]  
Ashcroft F.M., 2000, Ion Channels and Disease
[3]  
Avanzini Giuliano, 2004, Expert Rev Neurother, V4, P519, DOI 10.1586/14737175.4.3.519
[4]   Ligand-gated channels [J].
Barry, PH ;
Lynch, JW .
IEEE TRANSACTIONS ON NANOBIOSCIENCE, 2005, 4 (01) :70-80
[5]  
Bridgland-Taylor M. H., 2006, Journal of Pharmacological and Toxicological Methods, V54, P189, DOI 10.1016/j.vascn.2006.02.003
[6]  
CALLANTINE MR, 1968, P SOC EXP BIOL MED, V128, P382
[7]   Pathomechanisms in channelopathies of skeletal muscle and brain [J].
Cannon, Stephen C. .
ANNUAL REVIEW OF NEUROSCIENCE, 2006, 29 :387-415
[8]   Antiarrhythmic drugs and cardiac ion channels: mechanisms of action [J].
Carmeliet, E ;
Mubagwa, K .
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 1998, 70 (01) :1-72
[9]  
Catterall W A, 1999, Adv Neurol, V79, P441
[10]  
Chambers C, 2003, COMB CHEM HIGH T SCR, V6, P355